End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,110 KRW | -2.04% | -6.28% | +32.03% |
Business Summary
Number of employees: 160
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Other Product
51.9
%
| 41,099 | 66.3 % | 33,326 | 51.9 % | -18.91% |
Peptic Stomach Ulcer Medication
24.1
%
| 8,418 | 13.6 % | 15,495 | 24.1 % | +84.06% |
Merchandise
7.1
%
| 5,359 | 8.6 % | 4,544 | 7.1 % | -15.20% |
Diabetes Medication
6.6
%
| 3,652 | 5.9 % | 4,265 | 6.6 % | +16.78% |
Other Central Nervous System Agents
4.2
%
| 558 | 0.9 % | 2,678 | 4.2 % | +379.63% |
Antipyretic, Analgesic and Anti-inflammatory
3.6
%
| 1,669 | 2.7 % | 2,315 | 3.6 % | +38.68% |
Mineral Preparations, Other Vitamin Preparations
1.4
%
| 699 | 1.1 % | 899 | 1.4 % | +28.68% |
Antispasmodics
0.8
%
| 453 | 0.7 % | 518 | 0.8 % | +14.38% |
Others
0.3
%
| 128 | 0.2 % | 174 | 0.3 % | +35.66% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
78.4
%
| 45,415 | 73.2 % | 50,371 | 78.4 % | +10.91% |
Overseas
21.6
%
| 16,621 | 26.8 % | 13,844 | 21.6 % | -16.71% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jae-Chul Kim
CEO | Chief Executive Officer | 63 | - |
Gyeong-Jae Seo
CTO | Chief Tech/Sci/R&D Officer | 58 | - |
Hwan-Bong Yu
BRD | Director/Board Member | 52 | 15-03-26 |
Kwang-Joo Park
AUD | Comptroller/Controller/Auditor | 75 | 15-03-26 |
Kang-Hyeon Jeong
AUD | Comptroller/Controller/Auditor | 76 | 15-03-26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jae-Chul Kim
CEO | Chief Executive Officer | 63 | - |
Gyeong-Jae Seo
CTO | Chief Tech/Sci/R&D Officer | 58 | - |
Hwan-Bong Yu
BRD | Director/Board Member | 52 | 15-03-26 |
In Kim
BRD | Director/Board Member | 73 | - |
Jong-Beom Lee
BRD | Director/Board Member | 62 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,898,263 | 8,713,118 ( 73.23 %) | 218,257 ( 1.834 %) | 73.23 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
POLARIS AI PHARMA CORP. 1.83% | 218,257 | 1.83% | 1,443,360 $ |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+32.03% | 77.94M | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- A041910 Stock
- Company Polaris AI Pharma Corp.